1-3 of 3
Mari Peltola
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histone deacetylase inhibition as a potential therapeutic in ERG-positive prostate cancer

Free
Mari Peltola, Kristiina Iljin, Maija Wolf, Henrik Edgren, Santosh Gupta, Sami Kilpinen, Matthias Nees, Olli Kallioniemi
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 685.
Published: 01 May 2007
View article titled, Histone deacetylase inhibition as a potential therapeutic in ERG-positive prostate cancer
Journal Articles

TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming

Free
Kristiina Iljin, Maija Wolf, Henrik Edgren, Santosh Gupta, Sami Kilpinen, Rolf I. Skotheim, Mari Peltola, Frank Smit, Gerald Verhaegh, Jack Schalken, Matthias Nees, Olli Kallioniemi
Journal: Cancer Research
Cancer Res (2006) 66 (21): 10242–10246.
https://doi.org/10.1158/0008-5472.CAN-06-1986
Published: 01 November 2006
View article titled, TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming
Open the PDF for TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic Reprogramming in another window
Includes: Supplementary data
Journal Articles

Integrated DNA/RNA microarray profiling of hormone-refractory clinical prostate cancers and metastases indicates deregulation of several pathways, including androgen/AR, Hedgehog, MAPK and neuroactive ligand/receptor signalling

Free
Maija K. Wolf, Henrik Edgren, Ian Mills, Annaïck Carles, Olivier Poch, Sami Kilpinen, Mari Peltola, Reija Autio, David Neal, Bohdan Wasylyk, Jack Schalken, Olli Kallioniemi
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 36.
Published: 15 April 2006
View article titled, Integrated DNA/RNA microarray profiling of hormone-refractory clinical prostate cancers and metastases indicates deregulation of several pathways, including androgen/AR, Hedgehog, MAPK and neuroactive ligand/receptor signalling